Volume | 10,164,980 |
|
|||||
News | (1) | ||||||
Day High | 132.42 | Low High |
|||||
Day Low | 131.08 |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Merck and Co Inc | MRK | NYSE | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
132.23 | 131.08 | 132.42 | 131.95 | 131.75 |
Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
---|---|---|---|---|---|
97,036 | 10,164,980 | US$ 131.82 | US$ 1,339,989,137 | - | 99.14 - 133.10 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
18:57:51 | 1 | US$ 131.95 | USD |
Merck (MRK) Options Flow Summary
Merck and Co Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
334.18B | 2.53B | - | 60.12B | 365M | 0.14 | 915.68 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Merck News
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical MRK Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 123.82 | 133.10 | 123.06 | 127.01 | 9,531,736 | 8.13 | 6.57% |
1 Month | 128.38 | 133.10 | 119.41 | 123.78 | 11,285,687 | 3.57 | 2.78% |
3 Months | 115.92 | 133.10 | 115.86 | 123.22 | 8,659,071 | 16.03 | 13.83% |
6 Months | 104.42 | 133.10 | 99.14 | 113.36 | 8,361,173 | 27.53 | 26.36% |
1 Year | 107.11 | 133.10 | 99.14 | 112.01 | 7,654,032 | 24.84 | 23.19% |
3 Years | 77.25 | 133.10 | 70.89 | 92.37 | 10,063,598 | 54.70 | 70.81% |
5 Years | 82.79 | 133.10 | 65.25 | 87.70 | 10,059,986 | 49.16 | 59.38% |
Merck Description
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the firm's sales are generated in the United States. |